Search Results

fruitful research space has led to more than 700 approved drugs over previous decades—but the two-year-old biotech

Plus: must-read chemokine and PTH1R papers, and new momentum across biotech—from Superluminal to Neurocrine

That money has gone to some 60 biotechs, much of it as early funding."

(“Inversago”), a clinical stage biotech company with a unique portfolio of CB1 inverse agonists, announced

Industry insights:  Metabolic GPCRs in the spotlight; receptor motion tracking tools; obesity treatment race Stop wasting talent:  When senior leaders spend nights copy-pasting data, your burn rate accelerates GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

Joanne Waldstreicher to its Board of Directors GPCR Therapeutics launches multiple myeloma trial Salipro Biotech organized by LINK-J Jounce takes the cash under amended deal with Gilead on anti-CCR8 antibody InterAx Biotech

Inês Pinheiro and Oliver Hartley from the Orion Biotechnology team on their recent study on Arylsulfatases Enter Agreement for Rhythm to Acquire Global Rights to Oral MC4R Agonist LB54640 Addex to Present at Biotech Conference Isomorphic Labs Announces Strategic Multi-Target Research Collaboration With Novartis Salipro Biotech

Our partner, Domain Therapeutics, will attend the SACHS 23rd annual biotech event in Europe. Dr. Therapeutics CEO Pascal Neuville to Discuss Game-Changing GPCR-Targeting Immunotherapies at Sachs Associates' Biotech

If you’re in GPCR discovery or biotech R&D, this is a masterclass in turning deep science into scalable David Parker spent years designing rare-earth europium probes. Partnerships, Not Just Sponsorships Behind every breakthrough assay is a web of collaborations that rarely

Industry News InterAx Biotech to Apply its Leading AI and Cell Signalling Technology to Support Target Validation for a Sosei Heptares GPCR Discovery Program Salipro Biotech and DyNAbind Announce Milestone Clinical Stage X4 Pharmaceuticals Announces Positive Phase 3 Results Showing Mavorixafor Reduced the Rate

When crystal structures were finally solved, the models aligned strikingly well—a rare and powerful validation Translational Impact for Drug Discovery While the Carlsson lab is rooted in academia, its impact extends into biotech

Submit a logo design by Nov 1st on the Logo Contest page. Chris Cargill Wins Executive of the Year at the Citeline Pharma Intelligence Awards Japan 2023 Salipro Biotech

unanswered questions about blockbuster weight-loss drugs Transforming Drug Discovery: Insights from Viva Biotech's

prestigious international award – exemplified by the fact that other winners this year are the co-founders of BioNTech

Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights Salipro Biotech (April 20 - 21, 2023) Swiss Biotech Day (April 24 - 25, 2023) SLAS Europe 2023 Conference and Exhibition

Anyone who joins before the change is fully grandfathered  — your rate stays locked, and your whole team GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

Discovery programs rarely fail because a molecule “did nothing.” Biology rarely gives one. It equips pharmacologists, discovery teams, and biotech leaders to see around mechanistic corners, recognize

In Episode 3 of 3  of our series with Celtarys Research , leaders from academia and biotech unpack what A quick rating on Spotify or Apple Podcasts — and a YouTube subscribe — helps us reach more scientists GPCR Premium Member And Lock in The Current Rate➤ https://www.ecosystem.drgpcr.com/gpcr-university-pricing

You can find more details about the speakers on the Live Talks page, and make sure to mark your calendar Operational Highlights and Consolidated Results for the Third Quarter and First Nine Months of 2023 InterAx Biotech

curriculum with your topic suggestions Weekly new releases  to stay ahead of the science Content built for biotech

Pairaudeau, CTO of Exscientia discuss transforming drug discovery using their AI-driven platform Salipro Biotech

26RFa by the pyroglutamylated RFamide peptide receptor Industry News NanoImaging Services and Cube Biotech

with your topic suggestions 🆕 Weekly new releases to stay ahead of the science 🧠 Content built for biotech

GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

GPCR scientists, translational pharmacologists, biotech discovery teams, platform company leaders, and

GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

When a compound’s off-rate is slower than its clearance, its biological effect outlives its plasma presence The on-rate/off-rate balance  matters: too tight, and penetration stalls; too loose, and efficacy dissipates The metrics shift: k_inact  (rate of inactivation) replaces static Ki values. k_inact/KI  becomes the Kenakin Content trusted by biotech, pharma, and academia 💎 $2999/year — one conference cost = a full

Mid-2025 How GPCR agonists, including antibodies, are shaping the future of metabolic care Salipro Biotech

Kenakin Content trusted by biotech, pharma & academia 💎 $2999/year — one conference cost = a full

Industry News Orion Biotechnology at the AACR 2023. (April 20 - 21, 2023) Swiss Biotech Day (April 24 - 25, 2023) NEW ASPET 2023 - American Society for Pharmacology